0,705€
-2,76%
Echtzeit-Aktienkurs Mesoblast Ltd.
Bid:
Ask:
Echtzeit-Chart der Mesoblast Ltd. Aktie
Börsenkurse Mesoblast Ltd.
Echtzeit Euro | - | - | - | - | 0,725€ | 2,84% |
gettex | - | - | - | - | 0,705€ | -2,76% |
Tradegate | - | - | - | - | 0,708€ | -2,41% |
Börse Stuttgart | - | - | - | - | 0,725€ | 2,84% |
Profil der Mesoblast Ltd. Aktie
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.